JP2001507342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001507342A5 JP2001507342A5 JP1998527715A JP52771598A JP2001507342A5 JP 2001507342 A5 JP2001507342 A5 JP 2001507342A5 JP 1998527715 A JP1998527715 A JP 1998527715A JP 52771598 A JP52771598 A JP 52771598A JP 2001507342 A5 JP2001507342 A5 JP 2001507342A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3275396P | 1996-12-17 | 1996-12-17 | |
| US60/032,753 | 1996-12-17 | ||
| PCT/US1997/021532 WO1998026773A1 (en) | 1996-12-17 | 1997-11-21 | Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001507342A JP2001507342A (ja) | 2001-06-05 |
| JP2001507342A5 true JP2001507342A5 (enExample) | 2005-07-14 |
Family
ID=21866631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52771598A Abandoned JP2001507342A (ja) | 1996-12-17 | 1997-11-21 | 神経疾患の治療および創傷治癒を促進するためのマトリックスメタロプロテイナーゼ阻害剤の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6340709B1 (enExample) |
| EP (1) | EP0946166B1 (enExample) |
| JP (1) | JP2001507342A (enExample) |
| AT (1) | ATE259640T1 (enExample) |
| AU (1) | AU737117B2 (enExample) |
| BR (1) | BR9714142A (enExample) |
| CA (1) | CA2264692A1 (enExample) |
| DE (1) | DE69727695T2 (enExample) |
| DK (1) | DK0946166T3 (enExample) |
| ES (1) | ES2212142T3 (enExample) |
| NZ (1) | NZ334925A (enExample) |
| PT (1) | PT946166E (enExample) |
| WO (1) | WO1998026773A1 (enExample) |
| ZA (1) | ZA9711279B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK282833B6 (sk) * | 1995-11-17 | 2002-12-03 | Warner-Lambert Company | Sulfónamidové inhibítory matricových metaloproteináz a farmaceutická kompozícia obsahujúca tieto inhibítory |
| NZ323329A (en) * | 1995-12-22 | 1999-02-25 | Warner Lambert Co | 4-phenyl-piperidin-1-yl butyric acid derivatives and medicaments |
| US6410580B1 (en) | 1998-02-04 | 2002-06-25 | Novartis Ag | Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| PL342009A1 (en) | 1998-02-04 | 2001-05-07 | Novartis Ag | Sulphonylamine derivatives capable to inhibit extracellular substance degrading metaloproteinases |
| WO2000024392A1 (en) * | 1998-10-26 | 2000-05-04 | Sumitomo Pharmaceuticals Company, Limited | β-AMYLOID FORMATION INHIBITORS |
| US6677360B2 (en) | 1998-12-16 | 2004-01-13 | Bayer Aktiengesellschaft | Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| US6420396B1 (en) * | 1998-12-16 | 2002-07-16 | Beiersdorf Ag | Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| EP1031349A1 (en) * | 1999-02-25 | 2000-08-30 | Bayer Aktiengesellschaft | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| JP4074043B2 (ja) | 2000-03-27 | 2008-04-09 | 株式会社資生堂 | 皮膚基底膜形成促進剤、人工皮膚形成促進剤及び人工皮膚の製造方法 |
| US6376524B1 (en) | 2000-06-21 | 2002-04-23 | Sunesis Pharmaceuticals, Inc. | Triphenyl compounds as interleukin-4 antagonists |
| AU2001271068A1 (en) * | 2000-07-18 | 2002-01-30 | Chugai Seiyaku Kabushiki Kaisha | Matrix metalloprotease inhibitors |
| CA2423868C (en) | 2000-09-29 | 2011-06-07 | Prolifix Limited | Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| AU2002212541A1 (en) * | 2000-11-23 | 2002-06-03 | British Biotech Pharmaceuticals Ltd | Ydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections |
| WO2003006006A1 (en) * | 2001-07-09 | 2003-01-23 | The Regents Of The University Of California | Use of matrix metalloproteinase inhibitors to mitigate nerve damage |
| GB0204159D0 (en) * | 2002-02-22 | 2002-04-10 | British Biotech Pharm | Metalloproteinase inhibitors |
| US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| MX2007001337A (es) * | 2004-08-02 | 2008-03-13 | Genmedica Therapeutics Sl | Compuestos para inhibir amina-oxidasas que contienen cobre y usos de los mismos. |
| GB0708507D0 (en) | 2007-05-02 | 2007-06-13 | Queen Mary & Westfield College | Substituted phosphonates and their use |
| US20090136718A1 (en) * | 2007-11-28 | 2009-05-28 | Paul Dacey | Reinforced Bonded Constructs |
| WO2010011302A1 (en) * | 2008-07-22 | 2010-01-28 | Chdi, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| WO2013033068A1 (en) | 2011-08-30 | 2013-03-07 | Stephen Martin Courtney | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| SG2014012926A (en) | 2011-08-30 | 2014-06-27 | Chdi Foundation Inc | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| MX372995B (es) | 2014-07-17 | 2020-04-13 | Chdi Foundation Inc | Metodos y composiciones para el tratamiento de trastornos relacionados con vih. |
| CN111249281B (zh) * | 2020-03-26 | 2020-11-24 | 徐州医科大学 | Trpml1特异性小分子抑制剂ml-si3的新用途 |
| WO2022066835A1 (en) | 2020-09-23 | 2022-03-31 | St. Jude Children's Research Hospital, Inc. | Substituted n-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein |
| KR102612229B1 (ko) * | 2021-05-21 | 2023-12-08 | 가천대학교 산학협력단 | N-[(4'-브로모[1,1'-바이페닐]-4-일)설포닐]-l-발린 또는 이의 약제학적으로 허용 가능한 염을 포함하는 아밀로이드 베타의 올리고머화 및 피브릴화 억제용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3784701A (en) * | 1970-09-21 | 1974-01-08 | American Cyanamid Co | Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain |
| US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| US5602156A (en) | 1993-09-17 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for inhibiting metalloproteinase expression |
| JP3787605B2 (ja) * | 1994-10-05 | 2006-06-21 | ダーウィン・ディスカバリー・リミテッド | ペプチジル化合物および金属プロテアーゼのインヒビターとしてのその治療的使用 |
| US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
| DK0828726T3 (da) * | 1995-06-02 | 2002-01-21 | Warner Lambert Co | Tricykliske inhibitorer af matrixmetalloproteinaser |
| SK282833B6 (sk) * | 1995-11-17 | 2002-12-03 | Warner-Lambert Company | Sulfónamidové inhibítory matricových metaloproteináz a farmaceutická kompozícia obsahujúca tieto inhibítory |
| NZ323329A (en) * | 1995-12-22 | 1999-02-25 | Warner Lambert Co | 4-phenyl-piperidin-1-yl butyric acid derivatives and medicaments |
| CZ294063B6 (cs) | 1996-05-17 | 2004-09-15 | Warner-Lambert Company | Bifenylsulfonamid, jeho použití a farmaceutický prostředek s jeho obsahem |
-
1997
- 1997-11-21 BR BR9714142-9A patent/BR9714142A/pt not_active Application Discontinuation
- 1997-11-21 CA CA002264692A patent/CA2264692A1/en not_active Abandoned
- 1997-11-21 WO PCT/US1997/021532 patent/WO1998026773A1/en not_active Ceased
- 1997-11-21 NZ NZ334925A patent/NZ334925A/xx unknown
- 1997-11-21 DE DE69727695T patent/DE69727695T2/de not_active Expired - Fee Related
- 1997-11-21 US US09/269,123 patent/US6340709B1/en not_active Expired - Fee Related
- 1997-11-21 PT PT97949584T patent/PT946166E/pt unknown
- 1997-11-21 EP EP97949584A patent/EP0946166B1/en not_active Expired - Lifetime
- 1997-11-21 DK DK97949584T patent/DK0946166T3/da active
- 1997-11-21 AT AT97949584T patent/ATE259640T1/de not_active IP Right Cessation
- 1997-11-21 AU AU77353/98A patent/AU737117B2/en not_active Ceased
- 1997-11-21 JP JP52771598A patent/JP2001507342A/ja not_active Abandoned
- 1997-11-21 ES ES97949584T patent/ES2212142T3/es not_active Expired - Lifetime
- 1997-12-15 ZA ZA9711279A patent/ZA9711279B/xx unknown